Rationale and Design of the Enoximone Clinical Trials Program
- 作者Brian D. Lowes; Simon F. Shakar; Marco Metra; Arthur M. Feldman; Eric Eichhorn; J. William Freytag; Michael J. Gerber; Jean-Francois Liard; Craig Hartman; Rick Gorczynski; Gwyn Evans; Jennifer V. Linseman; Jennifer Stewart; Alastair D. Robertson; Ellen B. Roecker; David L. Demets; Michael R. Bristow
- 卷第11卷
- 期第9期
- 文件大小299.26KB
- 发表时间2005
- DOI10.1016/j.cardfail.2005.10.013
- 页码659-669
Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) TrialCheitlin, M.D. · Yearbook of Cardiology · 2008
Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) TrialCheitlin, M.D. · Yearbook of Medicine · 2008
Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) TrialColucci, W. S.; Kolias, T. J.; Adams, K. F.; Armstrong, W. F.; Ghali, J. K.; Gottlieb, S. S.; Greenberg, B.; Klibaner, M. I.; Kukin, M. L.; Sugg, J. E. · Circulation · 2007